A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The r ...

The brain isn’t the only place where MS lesions can develop — the disease can also attack the spinal cord, ... In relapsing-remitting MS, ... This leads to inflammation and scarring. [2] ...

To classify the brain as healthy or with lesions and to determine the lesion location if there exists a lesion in the brain, we employed various machine learning classifiers available in the ...

These patients typically have a relapsing-remitting disease course, with more frequent relapses and a higher lesion burden than adults. They also tend to progress to secondary progressive MS at a ...

Vidofludimus calcium is currently being evaluated in phase 3 clinical trials for the treatment of relapsing MS. In a phase 2 clinical trial, it has shown therapeutic activity in relapsing-remitting MS ...

In a phase 2 clinical trial, it has shown therapeutic activity in relapsing-remitting MS patients, significantly reducing brain lesions and demonstrating encouraging results in reducing confirmed ...

MRI scans revealed no new T1 gadolinium-enhancing lesions, which show active inflammation in the brain. In patients who had initially received the placebo and then switched to fenebrutinib, the ...

Participants were aged 18 to 55, met the 2017 McDonald criteria for relapsing MS, had an Expanded Disability Status Scale (EDSS) score of 5.5 or lower, and had either one relapse in the past year, two ...